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Abstract
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant proliferative
disorder that may progress to multiple myeloma, a malignant plasma cell neoplasia.We evalu-
ated differential scanning calorimetry (DSC) as an experimental tool for differentiating serum
samples of MGUS patients from healthy individuals. DSC thermograms can be used for moni-
toring changes in the serum proteome associated with MGUS. MGUS patients showed great
variability in serum thermogram characteristics, which depended on the IgG, IgA or IgM iso-
types and/or the κ or λ light chains. Thermogram feature parameters distinguished patients
with MGUS from healthy people. Serum samples, named as non-MGUS, were also collected
from patients with subjacent immunological pathologies who were discarded of having MGUS
through serum immunofixation. They were used to verify the sensitivity of DSC for discriminat-
ing MGUS from related blood dyscrasias. Only some DSC thermogram feature parameters dif-
ferentiated, to a lesser extent, betweenMGUS and non-MGUS individuals. We contemplate
DSC as a tool for early diagnosis and monitoring of MGUS.
Introduction
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma cell
proliferative disorder associated with a life-long risk of progression to multiple myeloma (MM),
a malignant neoplasia [1–3]. MGUS etiology remains unclear, yet several studies support a role
of both genetic and environmental factors in its development [1,2]. It is the most common
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plasma cell dyscrasia, prevalent in about 3% of the general population aged 50 years and older
[4]. In contrast to the great diversity of normal immunoglobulins, in monoclonal gammopathies
a single abnormal cell line predominates, which may produce an intact immunoglobulin, free
light chains without heavy chains (often both intact and free), and rarely only heavy chains [1].
Furthermore, each abnormal cell line produces only a κ or λ light chain, but never both of them.
Therefore, several distinct clinical subtypes (non-IgMMGUS, IgMMGUS, and light-chain
MGUS) have emerged fromMGUS as a disease identity [1]. MGUS is defined as having serum
M-protein (monoclonal immunoglobulin)< 3 g/dL, clonal plasma cell population in the bone
marrow< 10%, and absence of end-organ damage [5,6]. It is unknown whether clinical hetero-
geneity can ultimately be attributed to simply identifying the original cell of clonal insult or rath-
er the result of a set of complex molecular events that may account for the different clinical
subtypes [1]. Little is known about the events that promote the evolution of MGUS and its pro-
gression to MM [7,8], yet, based on more than 75,000 individuals, it has been shown that all pa-
tients who eventually developed MMwere previously diagnosed with MGUS [2].
Several techniques have been traditionally used to detect MGUS. Selection of the preferred tech-
nique and correct interpretation of data often depends on an understanding of the immunological
basis and pathological conditions associated withMGUS [1,4,9]. Benefit may be expected from anal-
yses using multiparametric immunophenotyping of plasma cells andmolecular biology methods, in-
cluding gene expression analysis [1,10], but it is very difficult to diagnose whichMGUS patients will
stay stable and those in whom progression toMMwill develop [1,5,7]. The status of theM-protein
may offer insight intoMM development, but this is not absolute, and thus there is a need to identify
other biomarkers. The human plasma/serum proteome has to be considered as a suitable specimen
for disease diagnosis and therapeutic intervention [11–13]. In clinical practice, it seems interesting to
evaluate selected serummolecular biomarkers inMGUS and in the asymptomatic phase of MM.
Differential scanning calorimetry (DSC) can be used to measure the thermal properties of dilute
protein solutions as a function of temperature, and it has emerged as a potential method in the
analyses of unfractionated blood plasma or serum [13–16]. For a pure protein, DSC provides a
unique temperature-induced denaturation profile (thermogram) with a characteristic melting tem-
perature and melting enthalpy. In a protein mixture, such as plasma or serum, the observed ther-
mogram is a composite of the denaturation behavior of the component proteins weighted
according to their concentration within the mixture [15,17]. DSC analyses of blood plasma and
serum have shown that thermograms obtained from samples of healthy people are highly repro-
ducible with characteristic melting temperatures and well-defined shape [13,16,18]. Serum/plasma
of patients suffering from a variety of pathologies showed DSC thermograms that were strikingly
different from the thermograms of healthy people [13,16]. Such differences may not be observed by
using serum protein electrophoresis [13]. Thermograms obtained from almost any pathological
state can be markedly different from one another and this leads to the growing interest in develop-
ing calorimetry assays as a clinical diagnostic tool for disease screening. Given that there are
grounds for considering that changes in the bulk serum proteome may correlate with the clinical
status of certain patients, we sought to substantiate the use of DSC to examine serum from patients
withMGUS. DSC thermograms of serum samples distinguished healthy samples fromMGUS indi-
viduals, and they showed a close connection with different characteristics of MGUS pathology. We
contemplate, therefore, DSC as a potential tool for the early diagnosis and monitoring of MGUS.
Materials and Methods
Study population and institutional approval
A total of 28 patients (16 men and 12 women) diagnosed with MGUS at the ‘Hospital Universi-
tario Son Espases’ (HUSE) (Palma de Mallorca, Spain), 6 healthy volunteer donors (4 men and
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2 women) from the ‘Fundación Banco de Sangre y Tejidos de las Islas Baleares’ (Balearic Is-
lands Blood Bank), Palma de Mallorca, Spain) and 11 non-MGUS individuals (5 men and
6 women)—defined below—from HUSE were recruited for this study. Demographic details are
documented in Table 1. The Clinical Research Ethics Committee of the Balearic Islands
(CEIC-IB) approved both the study protocol and patient consent procedures (IRB#: IB 1914/
12 MB). All the enrolled volunteers gave written informed consent for their blood to be used in
this study.
The diagnosis of MGUS was based on standard clinical criteria [4] implemented in HUSE.
MGUS patients had serumM-protein concentration< 3 g/dL. They were classified according
to the monoclonal serum protein as: IgG κ, IgG1-κ subclass, IgG λ, IgA κ, IgA λ, IgM κ, and
IgM λ (Table 1). Control groups consisted of both healthy volunteers and a clinical group
named as non-MGUS. This non-MGUS group was formed of individuals with subjacent im-
munological pathologies that were initially suspected of having MGUS—from consideration of
some clinical parameters (serum protein electrophoresis among them)—but who were after-
wards ruled out of suffering fromMGUS by serum immunofixation. All healthy control volun-
teers were negative in the analytical tests for HIV, Hepatitis B and C, and Treponema
pallidum infections.
Blood sera coded and stored by the Biobank HUSE or the ‘Fundación Banco de Sangre y
Tejidos de las Islas Baleares’ were de-identified before they were delivered to the basic science
team. In this way, all serum samples were anonymized and blinded for unbiased data collec-
tion. Associated demographic information was collected by the clinical study personnel and
provided to the basic science team for data analysis.
Serum sample collection and preparation
Serum samples of MGUS and non-MGUS patients were obtained at the time of routine clinical
procurement. Blood samples from healthy donors were obtained through volunteer donation.
Sample collection and handling were conducted according to the approved experimental pro-
tocols. Briefly, blood collected in 9 mL red-top glass tubes with serum clot activator (Vacuette
España, San Sebastian de los Reyes, Spain) were allowed to stand for 30 min at room tempera-
ture and centrifuged at 4.000 rpm in a Heraeus Megafuge (Heraeus SA, Madrid, Spain) for
15 min. Separated serum was transferred into polystyrene tubes (Deltalab, Barcelona, Spain)
and stored at 4°C, for less than 48 h before analysis, or at -80°C until use (less than one
month). Every serum sample (150 μl) was dialyzed in Slide-A-Lyzer MINI Dialysis Units 2K
MWCO (Thermo Scientific, Cultek, Madrid, Spain) for 20 h at 4°C against 100 mL of a solu-
tion consisting of 10 mM sodium phosphate, 150 mM NaCl and 15 mM sodium citrate (pH
7.4). The dialyzed samples and the dialysis buffer were filtered using a hydrophobic Millex-HV
PVDF 0.45 μm filter (non-sterile 33 mm) (Merck-Millipore, Madrid, Spain). Dialyzed serum
samples were 20-fold diluted using filtered dialysis buffer and analyzed immediately.
Total protein concentration in the serum samples was determined colorimetrically in micro-
plates by using the Pierce BCA Protein Assay Kit (Thermo Scientific, Cultek, Madrid, Spain).
Differential scanning calorimetry (DSC) analysis
DSC measurements were performed using a Nano DSC microcalorimeter (TA Instruments,
Cerdanyola del Valles, Spain). Samples were scanned from 30° to 95°C at a scan rate of 1°C/
min. Filtered dialysis buffer was used as reference solution. DSC scans were performed in du-
plicate to ensure the reproducibility of the thermogram profiles for all samples. Data were ana-
lyzed using NanoAnalyze software, v. 2.3.6 (TA Instruments). Raw data were corrected for the
baseline (buffer vs. buffer) and normalized to the total protein concentration. Normalized
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serum DSC scans were corrected for non-zero baselines by a linear baseline fit. Thermograms
were plotted as excess specific heat capacity (cal/°C.g) vs. temperature (°C).
Analysis of thermogram feature parameters
Several thermogram feature parameters were evaluated for quantitative DSC analysis. We cal-
culated: Tmax, the temperature of the peak maximum, the plot area, Cp1
ex, the excess specific
heat capacity of the first thermal transition, Cp2ex, the excess specific heat capacity of the sec-
ondary thermal transition, Cp1ex/Cp2ex, the ratio of the excess specific heat capacities of the
first and second transitions, and TFM, the first moment temperature (the temperature corre-
sponding to the geometric center of the thermogram), which was calculated as described else-
where [19]. For every thermogram, all relevant local peaks were analyzed to estimate the
temperature maxima of the primary transitions in the 62–65°C range (first thermal transition)
and in the 69–75°C range (second thermal transition) and their corresponding excess specific
heat capacities, Cp1ex and Cp2ex.
Peak deconvolution analysis was performed for the average DSC thermograms of serum
samples from healthy individuals. However, that was discarded for MGUS samples and non-
MGUS clinical control thermograms because of the wide variability in their DSC profiles
(see Results).
Statistical analysis
Box charts were used for graphical representation of DSC thermogram feature parameters, and
to statistically compare differences in the distribution between each study group. Multiple
group statistical comparisons of the thermogram feature parameters were assessed by the non-
parametric Kruskal-Wallis test. The unpaired Mann-Whitney U test for unequal medians was
used for pairwise comparisons between every group. All the statistical analyses were undertak-
en with the Sage software (v. 6.2) [20], which is freely available at http://www.sagemath.org.
Actual p values were calculated, and p< 0.05 was ascribed as statistically significant.
Results
Influence of storage temperature and handling of serum samples on
DSC thermograms
To perform our studies on MGUS, we gathered sera from patients and healthy individuals ob-
tained at two different institutions: Hospital Universitario Son Espases (HUSE) and ‘Fundación
Banco de Sangre y Tejidos de las Islas Baleares’ (Balearic Islands Blood Bank). It was, therefore,
our first concern to check whether sample handling and storage conditions, or any delay in
Table 1. Patient demographics and disease characteristics.
Sample seta Number of samples Male/Female Age range Age (mean ± SD)
MGUS patientsb 28 16/12 47–88 71 ± 11
Healthy controls 6 4/2 24–66 41 ± 9
Non-MGUS patientsc 11 5/6 47–84 70 ± 14
a All serum samples were from white people.
bMGUS encompasses serum samples of the following isotypes: IgG κ (10 samples), IgG1-κ subclass (2), IgA κ (2), IgM κ (2) IgG λ (7), IgA λ (3), IgM λ (2).
cNon-MGUS includes serum samples from patients with subjacent immunological pathologies who were ruled out of having MGUS through
serum immunoﬁxation.
doi:10.1371/journal.pone.0120316.t001
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delivering them to the DSC facility, may produce differences in the quality of the samples used,
as it was to preserve sample integrity that can affect serum protein profiling [21]. To this end,
several serum aliquots from healthy or MGUS individuals were either analyzed immediately
after their acquisition or stored several days at 4°C before the analysis. No major differences
were observed between the thermograms of samples immediately analyzed and those stored at
4°C up to seven days (Fig. 1), but there was a time-dependent decrease in the plot area, and a
peak was observed ~ 92°C after seven days storage. Therefore, samples were not stored at 4°C
for more than two days before their analysis.
DSC analysis of healthy controls and MGUS serum samples
Sera from healthy control individuals showed a complex multimodal DSC profile (Fig. 2A) in
line with those previously reported for serum and plasma samples [14,16,19,22]. For the cur-
rent study, control thermograms were averaged and they formed the study healthy control pro-
file. Peak deconvolution analysis of the mean thermogram yielded five peaks, not linked to
individual protein components of the serum proteome, with Tm values 62.7°C, 65.8°C, 68.2°C,
70.3°C and 84.1°C, respectively. In the analysis of the healthy thermogram characteristics, we
only considered the two peaks that mainly contributed to the cumulative fitted curve (Tm val-
ues 62.7°C and 70.3°C, respectively). A (Cp1ex/ Cp2ex) ratio of 1.55 characterized the average
healthy control profile, in keeping with previously reported values [18]. Table 2 shows the ther-
mogram feature parameters of the healthy control group, which includes the median Tmax
value, first moment temperature (TFM), and the plot area. Thermograms of sera from individu-
als having MGUS differed from healthy, control, ones (Fig. 2A-C) except in one case that re-
sembled the healthy DSC profile as implied from both the thermogram shape and the Tm
value (cf. Figs. 1B and 2B). Tentatively, this might denote that this serum sample belonged to a
patient who was in an “early-stage” of MGUS development.
For an unbiased DSC analysis of diseased sera, MGUS samples were gathered in two major
groups based on the light chain associated to the different monoclonal immunoglobulin heavy
chains. The resulting groups are named through this paper as MGUS-κ and MGUS-
λ, respectively.
Several serum samples from MGUS-κ patients that overexpressed the IgG κ isotype had
DSC profiles with a first peak transition in the range 63–67°C and a second transition at
~70–72°C, accompanied by a shoulder at higher temperatures (~77–80°C) (Fig. 2B). Further-
more, some serum samples from patients overexpressing IgG κ (Fig. 2C)—including the IgG1-
κ subclass (Fig. 2D)—, IgM κ or IgA κ isotypes (Fig. 2E) showed dissimilar thermograms with
clear qualitative differences, which may reflect different stages in the development of MGUS,
and the idiosyncrasy of individual serum samples. They showed a defined Tm peak in the
61–63°C range, with large variation in its height value (0.16–0.4 cal/g.deg), together with a
main complex peak with Tm values in the 68–77°C range. The DSC thermogram regions
around 62–65°C and 69–71°C have been regarded as being dominated by the denaturation of
serum albumin and immunoglobulins, respectively [17]. A shoulder around 82–83°C was also
observed in some IgG κ, IgA κ and IgM κ thermograms (Fig. 2B-D), which may correspond to
the unfolding of transferrin [14] or to a thermally-stabilized transition of other protein because
of the serum interactome network. Compared with the average healthy control, the MGUS-κ
thermograms were shifted to higher melting temperatures, but, given the large variability ob-
served in the DSC profiles, an average thermogram that could represent the whole diseased
MGUS-κ group was not calculated. Nevertheless, DSC thermograms of MGUS-κ serum sam-
ples show changes in both the ~62°C and ~70–75°C regions that might be associated with the
pathologic status. Table 2 summarizes the quantitative assessments of Tmax (temperature of the
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peak maximum), Cp1ex and Cp2ex values at the primary transitions (first and second thermal
transitions) and their ratio. The total peak area and the first moment temperature (TFM) were
also quantified to better describe the thermogram profile (Table 2). The thermogram character-
istics quantified for every MGUS-κ sample did not seem to discriminate among IgG κ, IgA κ,
and IgM κ isotypes, although this should be treated with caution because of the small experi-
mental sample size which was dictated by the availability of diseased serum samples.
Most DSC thermograms of the MGUS-λ serum samples had a defined peak ~ 62°C with
large variance in their height values (0.18–0.28 cal/°C.g), and a second transition (~69–71°C)
accompanied by a shoulder in the 75–77°C range (Fig. 3), yet some serum samples of the IgG λ
and IgM λ isotypes did not follow such general profile (Fig. 3B). An additional ~ 83°C peak
was sometimes observed (Fig. 3), which, as mentioned above, might correspond to the unfold-
ing of transferrin or to a thermally-stabilized transition of other protein owing to the serum
interactome network. As for the MGUS-κ group, a large variance in the thermogram parame-
ters was apparent in the MGUS-λ group (Table 2).
Fig 1. DSC thermograms of blood serum samples stored at 4°C for different periods of time. (A)
Thermograms of healthy serum samples analyzed immediately (0 days), and after 2, or 7 days. (B) MGUS-κ
serum samples (experimental group based on the κ light chain that is associated with different monoclonal
immunoglobulin heavy chains) analyzed after 0, 2, and 7 days.
doi:10.1371/journal.pone.0120316.g001
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Fig 2. DSC thermograms of serum samples from healthy individuals and patients with MGUS-κ. Samples were gathered as MGUS-κ based on the κ
light chain that was found associated with different monoclonal immunoglobulin heavy chains. (A) A set of thermograms obtained from six healthy (control)
serum samples. The panel shows an average healthy control plot (dashed brown line) and the standard deviation (shadow). (B) A set of thermograms of
serum samples obtained fromMGUS patients with IgG κ subtype. (C) Another set of themograms obtained from individuals with IgG κ subtype. For the ease
of visualization, thermograms were clustered in either panel B or C based on the similarity of their DSC profiles. (D) Thermograms from patients having IgG1-
κ subclass. (E) Thermograms from patients having IgA κ (black) or IgM κ (red) subtypes. For the sake of comparison, the average healthy (control)
thermogram (dashed brown line) is presented in all the panels.
doi:10.1371/journal.pone.0120316.g002
Calorimetric Characterization of MGUS
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Non-MGUS clinical control samples
We also analyzed serum samples from patients with subjacent immunological pathologies,
named as non-MGUS, suspected of having MGUS, but ruled out of having such pathology by
serum immunofixation. Non-MGUS serum samples were used to examine the sensitivity of
DSC to discriminate between MGUS patients and those suffering from related dyscrasias.
Non-MGUS samples showed two types of thermogram shapes that were different from those
of healthy controls. For the ease of analysis, we grouped the non-MGUS thermograms accord-
ing to their shape similarities (Fig. 4). A first group displayed a peak transition in the range
65–67°C accompanied by a shoulder at ~70–73°C (Fig. 4A). A second group showed a narrow
first transition (61.8–62.8°C) with a large variation in height value (0.19–0.41 cal/°C.g), fol-
lowed by a complex peak with Tm values in the 68–71°C range (Fig. 4B). Table 2 summarizes
the thermogram feature parameters of the non-MGUS serum samples.
Using DSC thermograms to uncover differences across healthy and
diseased groups
Differences in DSC thermograms can indicate a connection between clinical MGUS status and
the thermogram characteristics, which might encompass diagnostic possibilities. We sought to
gain unbiased insights into whether the thermogram feature parameters described above could
be representative indicators of disease-associated changes in the serum proteome. Box plots
were used to display variations in MGUS, non-MGUS and healthy serum samples (Fig. 5).
These plots compare the distribution of six thermogram feature parameters across the dis-
eased and healthy groups. We scrutinized whether the six thermogram characteristics showed
significant differences among the different groups of serum data (that is if they showed statisti-
cal differences that can be used for distinguishing data for every diseased and healthy groups,
as well as among them). In general, trends are observed in the thermogram parameters (Fig. 5)
that were statistically corroborated by the non-parametric Kruskal-Wallis one-way analysis of
variance. All thermogram feature parameters showed significantly different median values (the
actual p values are given in the legend to Fig. 6). This statistical test indicated that significant
differences existed among groups, but it did not identify “where” the differences in thermo-
gram characteristics occurred across the different experimental groups. We used, therefore, an
unpaired Mann-Whitney U test for unequal medians to evaluate pairwise whether the
Table 2. Thermogram feature parameters of each clinical group, including “healthy” and non-MGUS sera controls.
Parameter Healthya MGUS-kappaa MGUS-lambdaa All-MGUSa non-MGUSa
Area (cal/g) 5.3 (4.9, 5.5) 6.2 (5.2, 6.5) 6.1 (6.0, 6.4) 6.2 (5.7, 6.5) 5.2 (5.1, 6.1)
Tmax (°C) 63.3 (62.7, 63.6) 69.9 (65.7, 72.6) 70.5 (69.3, 71.1) 70.3 (66.2, 71.1) 66.6 (65.5, 71.2)
Cp1ex (cal/°C.g) 0.42 (0.38, 0.44) 0.29 (0.19, 0.32) 0.24 (0.18, 0.28) 0.25 (0.18, 0.30) 0.24 (0.19, 0.41)
Cp2ex (cal/°C.g) 0.25 (0.20, 0.26) 0.39 (0.34, 0.42) 0.42 (0.40, 0.45) 0.40 (0.36, 0.43) 0.38 (0.32, 0.39)
Cp1ex/Cp2ex 1.69 (1.5, 2.1) 0.71 (0.50, 1.00) 0.59 (0.40, 0.70) 0.63 (0.40, 0.80) 0.65 (0.50, 0.90)
TFM (°C) 68.2 (67.6, 68.4) 69.8 (69.1, 70.6) 70.3 (69.9, 71.2) 70.0 (69.2, 70.9) 69.7 (69.0, 70.6)
a Median value (lower and upper value in the ﬁrst (25th) and third (75th) quartiles).
Tmax, temperature of the peak maximum.
Cp1ex, excess speciﬁc heat capacity of the ﬁrst thermal transition.
Cp2ex, excess speciﬁc heat capacity of the second thermal transition.
Cp1ex/Cp2ex, ratio of the excess speciﬁc heat capacities of the ﬁrst and second transitions.
TFM, ﬁrst moment temperature.
doi:10.1371/journal.pone.0120316.t002
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Fig 3. DSC thermograms of serum samples from patients with MGUS-λ. Samples were gathered as
MGUS-λ based on the λ light chain that was found associated with the different monoclonal immunoglobulin
heavy chains. (A) A set of thermograms of serum samples obtained from patients with IgG λ subtype. (B) A
set of thermograms from individuals with MGUS IgG λ subtype (black) or IgM λ subtype (red) grouped
together to highlight their similar shape. (C) Several thermograms from patients having IgA λ (continuous
black and red plots, and dashed black plot) or IgM λ (dashed red plot) subtypes grouped together because
they show similar shapes. For the sake of comparison, the average healthy (control) thermogram is
presented in all the panels.
doi:10.1371/journal.pone.0120316.g003
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thermogram parameters can distinguish the different serum groups. Fig. 6 summarizes the
comparisons between every set of serum samples and any of the other sets. In this way, we did
not only compare healthy serum data with those belonging to MGUS-λ or MGUS-κ groups,
but also to non-MGUS set and “all-MGUS” (which compiled λ plus κ sets). The actual p values
for every pairwise comparison are itemized inside the panels displayed in Fig. 6. For several
thermogram feature parameters, the observed differences were highly significant. Hence, some
thermogram features provided us with reliable quantitative measurements of the changes in
DSC profiles.
The six thermogram feature parameters differentiated sera of the healthy group from those
of the pathological MGUS and non-MGUS groups (see Figs. 5 and 6). The exception was, from
a statistical point of view, the DSC thermogram area in the comparison between the healthy
and the non-MGUS groups (upper left panel in Fig. 6). The temperature of the peak maximum,
Fig 4. DSC thermograms of serum samples from non-MGUS individuals. Non-MGUS refers to serum
samples from individuals with subjacent immunological pathologies who were ruled out of having MGUS
through serum immunofixation. (A), (B) Two sets of themograms obtained from non-MGUS individuals. For
the ease of visualization, the experimental thermograms were clustered in either panel based on the similarity
of the shapes of their DSC profiles. For the sake of comparison, the average healthy (control) thermogram is
presented in all the panels.
doi:10.1371/journal.pone.0120316.g004
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Tmax, increased in the MGUS group. The MGUS-κ group showed a wide distribution of Tmax
values that contrast with the narrow range of the MGUS-λ group. Both Tmax and TFM values
increased in the diseased groups when compared to the healthy, control, thermograms (Fig. 5).
The first moment temperature (TFM) that is a measure of the thermogram shape redistribution,
increased in MGUS compared to the healthy control.
The excess heat capacities of the low temperature transitions (Cp1ex) were smaller for all the
pathological groups than for the healthy one (Fig. 5). This transition would mainly encompass
the unfolding of serum albumin [14], and the temperature shift suggests thermal stabilization
of that protein in the diseased state by other serum components [17]. Unlike Cp1ex, Cp2ex val-
ues increased for all diseased groups (Fig. 5). Cp2ex enhancements in people with MGUS can
be produced by the thermal stabilization of the unfolding of the pathological monoclonal im-
munoglobulin (M-protein) through its interaction with other components of the diseased sera,
Fig 5. Box chart representations of thermogram feature parameters. For each panel, boxes from left to
right represent serum samples from (a) healthy controls, (b) MGUS-κ, (c) MGUS-λ, (d) All-MGUS (which
compiles MGUS-κ and MGUS-λ samples together) and (e) non-MGUS. The bottom and top box edges
indicate the 25th and 75th percentiles. Within the box, the median value is indicated by the horizontal line, and
the mean by the cross inside the box. The whiskers extend from the ends of the boxes to the minimum and
maximum experimental values.
doi:10.1371/journal.pone.0120316.g005
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concurring with the denaturation of immunoglobulins described elsewhere [17]. The differ-
ences observed between all-MGUS and non-MGUS groups, most significantly in the plot area
(Figs. 5 and 6), would reflect that in both blood dyscrasias the immunoglobulins—seemingly
the M-protein in MGUS—are actively participating in interactions with other protein and pep-
tide components of the diseased sera in what is defined as the “interactome” [11], which oc-
curred regardless of the exact serum composition that would differentiate these groups.
Comparison between MGUS-κ or MGUS-λ groups and the healthy one revealed highly sig-
nificant differences in all the thermogram feature parameters (Fig. 6). Therefore, DSC clearly
differentiated healthy individuals from those with MGUS. Moreover, the Cp1ex/ Cp2ex ratio
values were different in the MGUS-κ or MGUS-λ groups (Table 2 and Fig. 5). On the other
hand, the thermographs of MGUS-κ, MGUS-λ isotypes and all-MGUS (MGUS-κ plus MGUS-
λ groups) differed significantly from the non-MGUS group in the plot area only (Figs. 5 and 6).
Notwithstanding the loose definition of the non-MGUS clinical group, it could still be differen-
tiated fromMGUS and the healthy serum samples (Fig. 6).
Fig 6. Differences in thermogram feature parameters across the serum sample groups. The thermogram feature parameters are identified at the top of
each panel. The analysis of the data by a non-parametric Kruskal-Wallis test revealed significant differences in the six thermogram parameters displayed in
the figure (Area, p = 9.82E-3; Tmax, p = 8.73E-3; Cp1
ex, p = 5.59E-3; Cp2ex, p = 4.26E-4; Cp1ex/ Cp2ex, p = 5.92E-4; TFM, p = 2.16E-3), indicating they can be
used to distinguish the different serum groups, and also validated the utilization of post-hoc pairwise comparisons. Differences between the serum sample
groups were examined for every thermogram parameter by the unpaired Mann-Whitney U test. The figure panels indicate “yes” or “no” to specify whether
statistically significant differences occurred (the actual p values are shown in the panels).
doi:10.1371/journal.pone.0120316.g006
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Discussion
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant stage that
can progress to MM, a malignant plasma cell neoplasia [1,2]. Unfortunately, there are no reli-
able biological markers that predict which individual with MGUS will progress to MM or relat-
ed conditions [1,8,23].
Here, we have presented evidences that DSC might be useful as a part of the diagnostic crite-
ria for MGUS. Serum samples from MGUS patients exhibited DSC profiles that differentiate
them from those of healthy people (Figs. 2 and 3). Discrimination between healthy and dis-
eased samples has also been described when DSC was used to explore other pathologies
[14,16,18,19,24,25]. A general feature of the DSC thermograms of MGUS serum samples was
their heterogeneity (Figs. 2–3), which could reflect differences in disease process and progres-
sion [3].
Each MGUS subtype follows its own course while displaying individualistic clinical tenden-
cies [1]. The DSC thermograms obtained would correspond to patients diagnosed of having
MGUS at diverse stages of disease development. MGUS process can take time before its clinical
diagnosed, thus the thermograms of MGUS might reveal the evolution (stages) of the disease.
The lack of a single DSC fingerprint for MGUS is consistent with that individual thermograms
could indicate different levels of progression of the disease, which it is in line with the abundant
differences in the thermogram characteristics described in sera of patients suffering from di-
verse secretory and non-secretory myeloma types [16,25].
The heterogeneity of DSC thermograms of MGUS disease might reflect disease-associated
changes in the serum proteome composition and/or stability of components that affected pro-
teome interactions. The DSC thermogram regions around 62–65°C and 69–71°C have been re-
garded as being dominated by the denaturation of serum albumin and immunoglobulins,
respectively [17]. Our results suggest that both thermogram regions can detect changes in the
composition of blood serum that are linked to the MGUS status. The presence of a pathological
M-protein, owing to the accumulation of a simple variety of immunoglobulin [1,2,9], would re-
sult in changes in the DSC thermogram feature parameters in serum samples fromMGUS pa-
tients because of altered proteome interactions. Monoclonal immunoglobulin is recognized as
a band of restricted migration on serum or urine electrophoresis (M-protein) [9], but, current-
ly, we lack enough clinical data that might allow us to correlate changes in M-protein content
and the evolution of MGUS to MM. The relatively small scale of our study precludes us from
concluding there is a correlation between the DSC thermograms of patients with MGUS and
disease progression, yet the differences observed in the thermogram sets might be related to
differences in the disease process and its progression to MM.
Differential diagnosis of MGUS is the determinant for starting therapy [26]. The differences
observed in excess of heat capacities among the different MGUS isotypes have a clear diagnos-
tic potential. It will be worth exploring further the Cp1ex/ Cp2ex ratio (Fig. 5) as a marker of dis-
ease progression. This thermogram feature is highly influenced in MGUS by the interaction of
the monoclonal immunoglobulin (M-protein) with other serum protein and peptides, some of
which have been described as helpful in MGUS diagnosis [27], even though no single protein is
a wholly reliable marker. A non-MGUS clinical control group was included in our DSC studies
(Table 1). In this experimental group, serum samples were collected from individuals showing
laboratory data compatible with MGUS, but who were ruled out of having it by serum immu-
nofixation. This is a heterogeneous experimental group as deemed by the large variance ob-
served among the DSC thermograms (Fig. 4). Although we have observed differences between
non-MGUS and MGUS pathological groups, it is likely that the limited availability of serum
samples precludes us from differentiating both diseased groups unambiguously. DSC analysis
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of serum samples may become a useful diagnostic procedure for MGUS. Our results emphasize
that the proteome that could be involved in the transition of MGUS to MM is heterogeneous.
DSC thermograms obtained from serum samples reflect clinical differences in protein levels,
especially those of the M-protein, and its interactions with other serum biomarkers. It is worth
indicating that heterogeneity in MGUS could be linked to ethnic factors [28]. Nevertheless, in
our study all samples consisted of blood sera of white people only (Table 1), thus we surmise
that ethnical factors had no substantial impact on the heterogeneity of the thermograms shown
in Figs. 2–4.
Before DSC could be introduced as a new diagnostic tool, it will be worth examining a larger
number of MGUS patients with long-term follow-up to estimate clear correlations between the
evolution of the DSC thermograms and disease development. A better understanding of the
MGUS pathogenesis and the developing new tools for diagnosis should allow us to define the
biological high-risk precursor disease and, ultimately, to develop early clinical
intervention strategies.
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